CELL THERAPY MANUFACTURING: AUTOLOGOUS VS. ALLOGENEIC STRATEGIES

December 14, 2023, 11:00 am – 1:30 pm ET, Online and Interactive

While related, scaling autologous and allogeneic cell therapies require vastly different manufacturing approaches, equipment, and technologies. Regardless of the platform chosen, implementing the right strategy early is the key to success. Our experts share their personal experiences and insight to help you anticipate challenges and implement better cell therapy strategies.

Meeting Agenda (all times ET and subject to change)

11:00 am – 11:15 am: Welcome + Meet and Greet Networking

11:15 am – 11:40 am: Conversation #1: Selecting the Right Technologies and Equipment to Support Your Cell Therapy Strategy

11:40 am – 12:05 pm: Conversation #2: Identifying Cost Savings to Improve Autologous Manufacturing Efficiency

12:05 pm – 12:30 pm: Conversation #3: Keys to Implementing the Right Manufacturing Strategy

12:30 pm – 1:30 pm: Deep Dive Networking

For more details on the program series, please contact:
Brian Caine
Co-Founder and Managing Director
Evaluating Biopharma, a Division of Cambridge Healthtech Institute
Phone: (+1) 908-809-0946
Email: bcaine@healthtech.com

For information regarding sponsorship, please contact:
Companies A-M
Phillip Zakim-Yacouby
Senior Manager, Business Development
Evaluating Biopharma, a Division of Cambridge Healthtech Institute
Phone: (+1) 781-247-1815
Email: pzakim-yacouby@healthtech.com

Companies N-Z
Aimee Croke
Senior Manager, Business Development
Evaluating Biopharma, a Division of Cambridge Healthtech Institute
Phone: (+1) 617-292-0777
Email: acroke@healthtech.com